|
Mar 11
|
CareDx Launches Two Expanded Indications for AlloSure Testing Services
|
|
Feb 20
|
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
|
|
Feb 14
|
Exploring Three High Growth Tech Stocks In The United States
|
|
Feb 13
|
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
|
|
Feb 12
|
Investing in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 187% gain
|
|
Feb 11
|
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 11
|
CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock?
|
|
Jan 2
|
High Growth Tech Stocks in the United States
|
|
Sep 26
|
Encompass Health Opens 9th Hospital in SC: More in the Pipeline?
|
|
Aug 29
|
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?
|
|
May 11
|
Earnings Update: Here's Why Analysts Just Lifted Their CareDx, Inc (NASDAQ:CDNA) Price Target To US$13.80
|
|
May 10
|
CareDx Reports Mixed Q1 2024 Results; Raises Annual Revenue Guidance
|
|
May 10
|
CareDx, Inc (NASDAQ:CDNA) Q1 2024 Earnings Call Transcript
|
|
May 9
|
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 9
|
CareDx Reports First Quarter 2024 Results
|
|
May 7
|
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
|
May 3
|
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 29
|
CareDx to Report First Quarter 2024 Financial Results
|
|
Apr 19
|
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 18
|
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
|